Social Rhythm in OCD Similar to Bipolar Disorder
Researchers evaluated the regularity and distribution of social rhythm in individuals with clinically significant OCD symptoms and the role of affect and symptom severity in subtypes of OCD.
Bipolar Disorders
Clinical Predictors Could Guide Lithium Dosage in Bipolar Disorder
A model comprising 6 clinical variables could be used to guide lithium dosage.
Substantial Reorganization of Structural Brain Networks Among Young Adults at High Risk for BD
This study recruited individuals aged 12-30 years who had first-degree relatives with BD I or II and those with no family history of mental illness.
Poor Sleep and Mood Closely Intertwined in People With Bipolar Disorder
Researchers used the ecological momentary assessment, actigraphy, and self-reported sleep measures to examine the relationship of sleep and mood in people with bipolar disorder.
Psychiatric Disorders Associated With Similar Risk as Other Comorbidities in Breakthrough COVID-19 Infections
Investigators at the San Francisco Veterans Affairs (VA) Health Care System evaluated VA health records between February 2020 and November 2021.
Commercial Smartphone Applications to Self-Manage Bipolar Disorder
This study recruited individuals with BD via advertisements on social media and through the Collaborative RESearch Team to study psychosocial issues in Bipolar Disorder (CREST.BD) website and its mailing list.
Bipolar Disorder Prescribing Trends Don’t Mirror Guidelines
Nearly half of adults newly diagnosed with bipolar disorder are treated with mood stabilizers and/or antidepressants. Few of them initially received guideline-recommended therapy.
Ketamine Infusions Improve Symptoms of Depression and Pain
Patients with treatment-resistant major depressive disorder or bipolar disorder without psychotic symptoms received intravenous infusions of 0.5 mg/kg ketamine 3 times per week for 2 weeks.
Substance Use Disorders Associated With Impaired Cognition in Bipolar Disorder
Investigators searched the PubMed, PsycINFO, and Embase databases from inception through February 2021 for studies describing the cognitive performance of patients with bipolar disorder with and without comorbid substance abuse disorder.
New Caplyta Dosage Strengths Approved for Specific Patient Populations
Caplyta is indicated for the treatment of schizophrenia and depressive episodes associated with bipolar I or II disorders, as monotherapy and as adjunctive therapy with lithium or valproate.
- Loading...
Loading...
Next post in Schizophrenia and Psychoses
Loading... 
Loading...